CDER New July 31, 2018

July 30, 2018

• FDA approves first treatment for rare adrenal tumors
• Drug Firm Annual Registration Status (updated)
• Drug Firm Annual Registration Status Download File (updated)
• National Drug Code Directory (updated)
• Ranier’s Rx Laboratory Issues Voluntary Recall of All Sterile Compounded Products Within Expiry Due to Lack of Sterility Concerns
• Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)